O. Trédan
Molecular Biology · 2007–2017
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 26 citations into it
Whom O. Trédan trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from O. Trédan's perspective
Ordered by how strongly the researchers O. Trédan trusts endorse each paper. Same corpus, a different order for every researcher.
- Pathology: Cancer cells compress intratumour vessels (Nature)
- Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
- Dissecting tumour pathophysiology using intravital microscopy (Nature Reviews. Cancer)
- Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. (American Journal of Pathology)
- Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors (Cancer Research)
- Angiopoietin-1 protects the adult vasculature against plasma leakage (Nature Medicine)
- Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics (Science)
- Transport of molecules across tumor vasculature (Cancer Metastasis Review)
- Openings between defective endothelial cells explain tumor vessel leakiness. (American Journal of Pathology)
- Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis (Science)
Their papers
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. (2015) — 959 citations
- MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer. (2017) — 1,431 citations
- LYMPHOPENIA AS A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL IN ADVANCED CARCINOMAS, SARCOMAS AND LYMPHOMAS (2009) — 757 citations
- Drug resistance and the solid tumor microenvironment. (2007) — 2,057 citations